Key Findings
Acetate accumulation is the primary driver of late-stage acidification in CHO-C cell lines engineered for PD-1/VEGF bispecific antibody production. In a fourteen-day bioreactor process, acetate concentrations climbed to between 1.75 and 1.80 grams per liter (approximately 30 millimoles per liter) between day ten and day fourteen. This metabolic shift caused the culture pH to drop below 6.4 by day fourteen, despite automated base addition, and led to a complete plateau in antibody expression after day twelve.
Technical Details
The study compared CHO-C (bispecific antibody) with CHO-B (monoclonal antibody targeting EGFRvIII) under identical conditions. While CHO-B maintained a steady pH of 7.05 and accumulated less than 0.3 grams per liter of acetate, CHO-C exhibited severe molecular deterioration. Analytical evaluations on day sixteen showed:
- A 16.2 percent increase in acidic charge variants.
- A decline in the primary monomeric peak from 50.97 percent to 36.46 percent.
- A 1.5 percent drop in overall purity due to antibody fragmentation.
Isotopic labeling with carbon-13 mass spectrometry revealed that exogenous pyruvate carbon directly enters the intracellular acetate pool in CHO-C cells, a phenomenon absent in CHO-B cells. Additionally, halting glucose feeding at day thirteen caused the pH to shift upward, but intracellular acetate levels remained largely unchanged, suggesting that glucose availability strongly influences the acid-producing metabolic mode.
Background & Context
Biopharmaceutical manufacturing typically monitors lactate as the main contributor to acidic conditions. However, this investigation demonstrated that in the CHO-C line, eight key tricarboxylic acid cycle intermediates remained below 0.5 grams per liter, confirming that acetate—not residual lactate—was the primary acidic byproduct. The process also showed a sharp reduction in cellular oxygen uptake rate, indicating impaired mitochondrial oxidative phosphorylation.
Significance & Outlook
The results highlight a specific metabolic vulnerability in bispecific antibody production where pyruvate conversion to acetate disrupts protein synthesis and quality. Identifying the link between glucose availability, pyruvate, and acetate accumulation provides a target for optimizing fed-batch cultivation to prevent late-stage acidification and product degradation.
Get our weekly technology intelligence — free
Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.
Subscribe Free — Weekly Tech Intelligence
By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.
- Your email and selected fields are used only to deliver the newsletter.
- We never share your information with third parties.
- You can unsubscribe anytime via the link in each email.
See our Privacy Policy for details.
Takes about a minute · Unsubscribe anytime



